Most PET studies of the serotonin 1A receptor in MDD used the receptor antagonist radioligand, [carbonyl-C11]WAY100635; however, the interpretation of the combined results has been contentious owing to reports of higher or lower binding in MDD with different outcome measures. Here, HTR1A is linked to major depressive disorder.